20 July 2026

Amedeo Smart

Independent Medical Education


Subscriber: th..@boehringer-ingelheim.com

HIV Infection

20 July 2026 | n=19

  1. Okello S, Graff M, Justice AE, Howard AG, et al.
    Methylation patterns linked to blood pressure in people with HIV exposed to ART reveal neurovascular and immune pathways: The MACS/WIHS Combined Cohort Study.
    AIDS 2026.

  2. Chen M, Chen H, Ma Y, Ding W, et al.
    Sequence Notes: Identification of a Novel HIV-1 Circulating Recombinant Form (CRF200_0755) in a Southern Border Region of Yunnan, China.
    AIDS Res Hum Retroviruses 2026.

  3. Geretti AM, Wang K, Leverette B, Hove K, et al.
    Impact of HIV-1 RNA Assay Selection on Low-Level Viremia and Clinical Trial Endpoint Interpretations.
    Clin Infect Dis 2026.

  4. Martin NK, Chaillon A, Vickerman P, MacGregor L, et al.
    Optimizing HCV Screening to Maximize Health Benefit Among Men Who Have Sex with Men in the United States: A Cost-Effectiveness Analysis.
    Clin Infect Dis 2026.

  5. Huang YS, Sun HY, Lin KY, Huang SH, et al.
    Birth in the neonatal HBV vaccination era and hepatitis B surface antigen seroclearance in people with HIV and HBV coinfection on tenofovir-containing antiretroviral therapy.
    Clin Infect Dis 2026.

  6. da Silva J, Tejan M, Pals S, Kalata N, et al.
    Correlates of Dolutegravir Resistance in Low- and Middle-Income Countries: A Combined Analysis of Drug Resistance Surveys in Four Countries.
    Clin Infect Dis 2026.

  7. Tram KH, Sherwood J, Mahaka I, Cameron M, et al.
    Projected Impact of U.S. PEPFAR Withdrawal on Zimbabwe and Implications for the Global HIV Response.
    J Acquir Immune Defic Syndr 2026.

  8. Hughes CS, Brown J, Murombedzi C, Chirenda T, et al.
    Cost-effectiveness of safer conception strategies for HIV-discordant couples in Zimbabwe.
    J Acquir Immune Defic Syndr 2026.

  9. El-Imam IA, Koudjra AR, Nampota-Nkomba N, Mkandawire F, et al.
    Adverse Birth Outcomes Associated with SARS-CoV-2 Infection Among Pregnant Women with and without HIV: A Longitudinal Cohort Study.
    J Acquir Immune Defic Syndr 2026.

  10. Vannappagari V, Albano JD, Mofenson L, Ragone L, et al.
    Pregnancy and Neonatal Outcomes Following Prenatal Exposure to Dolutegravir: Findings From the Antiretroviral Pregnancy Registry.
    J Acquir Immune Defic Syndr 2026.

  11. Guillaume D, Olson S, Dionne JA, Alcaide ML, et al.
    Prevalence and predictors of abnormal cervical cytology among women living with HIV and without HIV from the MACS/WIHS combined cohort study.
    J Acquir Immune Defic Syndr 2026.

  12. Hertz JT, Rahim F, Wang C, Vaidyanathan A, et al.
    Optimizing Antihypertensive Care for Tanzanians Living With HIV: Effectiveness Outcomes From the COACH Pilot Trial.
    J Acquir Immune Defic Syndr 2026;101:896-906.

  13. Moysi E, Sharma AA, O'Dell S, Georgakis S, et al.
    A favorable follicular helper CD4 T cell programming characterizes neutralization activity in chronic HIV infection.
    J Clin Invest 2026.

  14. Le Guillou AV, Marcus JL, Krakower DS, Violette LR, et al.
    Potential Risks and Benefits of Low-Barrier Access and Monitoring for HIV Preexposure Prophylaxis: A Modeling Study.
    J Infect Dis 2026.

  15. Wohl DA.
    Do They, or Don't They? Integrase Strand Transfer Inhibitors, Tenofovir Alafenamide, and Excessive Weight Gain in People with HIV.
    J Infect Dis 2026.

  16. Vimonpatranon S, Ssemaganda A, Phuang-Ngern Y, Sajjaweerawan C, et al.
    Impact of early antiretroviral treatment on tissue resident memory CD4+ T cells in the gastrointestinal tract.
    J Infect Dis 2026.

  17. Peng Q, Wong YC, Cheng WY, He Y, et al.
    Safety and Immunogenicity of a PD-1-Enhanced HIV-1 Therapeutic DNA Vaccine: A Randomized, Double-Blind, Placebo-Controlled, Dose-Escalating Phase I Clinical Trial in People With HIV-1 on Antiretroviral Therapy.
    J Infect Dis 2026.

  18. Moraleda C, Tagarro A, Dominguez-Rodriguez S, Musiime V, et al.
    Empirical treatment with valganciclovir in infants living with HIV and hospitalised with severe pneumonia in Africa: a multicentre, open-label, factorial, randomised, controlled, superiority trial.
    Lancet 2026.

  19. Ferrand RA, Dauya E, Chikwari CD, Bandason T, et al.
    Author Correction: Integrated community-based HIV and sexual and reproductive health services for youth: a cluster-randomized trial.
    Nat Med 2026.


Display articles in


Amedeo HIV Infection

Data Origin

You selected the following journals for your Amedeo HIV Infection newsletter:

AIDS, AIDS Res Hum Retroviruses, Ann Intern Med, BMJ, Clin Infect Dis, J Acquir Immune Defic Syndr, J Clin Immunol, J Clin Invest, J Infect Dis, J Med Virol, J Virol, JAMA, Lancet, N Engl J Med, Nat Med, Pediatr Infect Dis J, Science, Virology.

To modify the journal selection, please open your Newsletter Management Page. If you don't remember the URL, please submit the email address of your Amedeo subscription.

Your email:



Amedeo HIV Infection

Five-Week Literature

27 July 2026

20 July 2026

13 July 2026

06 July 2026

29 June 2026


20 July 2026

Multidisciplinary Journal Club

    No data available 2026-07-20.


Privacy Policy